Skip to main content
Log in

Intrastriatal Injection of 5,7-Dihydroxytryptamine Decreased 5-HT Levels in the Striatum and Suppressed Locomotor Activity in C57BL/6 Mice

  • Published:
Neurochemical Research Aims and scope Submit manuscript

Abstract

Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 5,7-dihydroxytryptamine (5,7-DHT) on striatal levels of dopamine (DA), 5-hydroxytryptamine (5-HT), and their metabolites, as well as on locomotor activity were investigated in C57BL/6 mice. The results showed that MPTP significantly increased locomotor activity and decreased striatal DA levels. However, injection of the serotonergic neurotoxin 5,7-DHT in the striatum, either alone or following high doses of MPTP, significantly decreased locomotor activity, and concomitantly decreased striatal levels of 5-HT and 5-HIAA. This study suggests that the increased locomotor activity may be due to increased striatal serotonergic activity which overcompensates for the DA deficiency. The locomotor hypoactivity, induced by 5,7-DHT, might be due to the decreased striatal levels of 5-HT and 5-HIAA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. Chia, L. G., Ni, D. R., Cheng, L. J., Kuo, J. S., Cheng, F. C., and Dryhurst, G. 1996. Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 5,7-dihydroxytryptamine on the locomotor activity and striatal amines in C57BL/6 mice, Neurosci. Let. 218:67–71.

    Google Scholar 

  2. Colotla, V. A., Flores, E., Oscos, A., Meueses, A., and Tapia, R. 1990. Effects of MPTP on locomotor activity in mice. Neurotoxicol Teratol. 12:405–407.

    PubMed  Google Scholar 

  3. Kordower, J. H., Felten, S. Y., Felten, D. L., and Gash, D. M. 1986. Behavioral sequelae following MPTP administration in mice. Pages 413–417, in: Markey, S. P., Castagnoli, N. J., Trevor, A. J., and Kopin, I. J. (eds), MPTP: A Neurotoxin Producing a Parkinsonian Syndrome. Oriando: Academic Press.

    Google Scholar 

  4. Grahame-Smith, D. G. 1971. Studies in vivo on the relationship between brain tryptophan, brain 5-HT synthesis and hyperactivity in rats treated with a monoamine oxidase inhibitor and L-tryptophan. J Neurochem. 18:1053–1066.

    PubMed  Google Scholar 

  5. Modigh, K. 1972. Central and peripheral effects of 5-hydroxytryptophan on motor activity in mice. Psychopharmacol. 23:48–54.

    Google Scholar 

  6. Mitra, N., Mohanakumar, K. P., and Ganguly, D. K. 1992. Dissociation of serotoninergic and dopaminergic componenets in acute effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice. Brain Res Bull 28:355–364.

    PubMed  Google Scholar 

  7. Euvrard, C., and Boissier, J. R. 1980. Biochemical assessment of the central 5-HT agonist activity of RU 24969 (a piperidinyl indole). Eur. J. Pharmacol. 63:65–72.

    PubMed  Google Scholar 

  8. Tricklebank, M. D, Forler, C., and Fozard, J. R. 1985. The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2-(di-n-propylamino) tetralin in the rat. Eur J Pharmacol. 106:271–282.

    Google Scholar 

  9. Rempel, N. L., Callaway, C. W., and Geyer, M. A. 1993. Serotonin 1B receptor activation mimics behavioral effects of presynaptic serotonin release. Neuropsychopharmacol. 8(3):201–211.

    Google Scholar 

  10. Jacoby, J. H., Lytle, L. D., and Nelson, M. F. 1974. Long-term effects of 5,7-DHT on brain monoamines. Life Sci. 14:909–919.

    PubMed  Google Scholar 

  11. Massotti, M., Scotti De Carolis, A., and Longo, V. G. 1974. Effects of three dihydroxylated derivatives of tryptamine on the behavior and on brain amine content in mice. Pharmacology Biochemistry and Behavior. 2:769–775.

    Google Scholar 

  12. Toyoshi, T., Ukiai, M., and Kameyama, T. 1995. Intrastriatal injection of opioid receptor agonists inhibits apomorphine-induced behavior in 6-hydroxydopamine-treated mice. Eur J Pharmacol. 294:637–643.

    PubMed  Google Scholar 

  13. Chia, L. G., Liu, S. P., and Lee, E. H. Y. 1992. Differential effects of deprenyl and MPTP on catecholamines and activity in BALB/C mice. NeuroReport. 3:777–780.

    PubMed  Google Scholar 

  14. Hu, S. C., Chang, F. W., Sung, Y. J., Hsu, W. M., and Lee, E. H. Y. 1991. Neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the substantia nigra and the locus coeruleus in BALB/C mice. J Pharm Exp Therap. 259:1379–1387.

    Google Scholar 

  15. Cheng, F. C., Kuo, J. S., Shih, Y., Lai, J. S., Ni, D. R., and Chia, L. G. 1993. Simultaneous measurement of serotonin, catecholamines and their metabolites in mouse brain homogenates by high-performance liquid chromatography with a microbore column and dual electrochemical detection. J Chromatogr. 615:225–236.

    PubMed  Google Scholar 

  16. Boschert, U., Amara, D. A., Segu, L., and Hen, R. 1994. The mouse 5-hydroxytryptamine 1B receptor is localized predominantly on axon terminals. Neurosci. 58(1):167–182.

    Google Scholar 

  17. Ueda, S., and Kawata, M. 1994. Regeneration of serotonergic immunoreactive fibers in the brain of 5,6-dihydroxytryptamine treated rat. J Himforsch. 35(1):159–180.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chia, LG., Ni, DR., Cheng, FC. et al. Intrastriatal Injection of 5,7-Dihydroxytryptamine Decreased 5-HT Levels in the Striatum and Suppressed Locomotor Activity in C57BL/6 Mice. Neurochem Res 24, 719–722 (1999). https://doi.org/10.1023/A:1020771211305

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1020771211305

Navigation